PacBio Grows Order Backlog in Q4; Sees Increased Interest in Microbial Sequencing

The company reported $280,000 in grant revenue during the quarter, along with a net loss of $36.4 million.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.